Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125302011 | 12530201 | 1 | I | 20150610 | 20160706 | 20160706 | PER | US-PFIZER INC-2015197068 | PFIZER | 70.00 | YR | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125302011 | 12530201 | 1 | PS | VFEND | VORICONAZOLE | 1 | Oral | 200MG, (1/2 TABLET TWICE A DAY, 1 TABLET Q DAY) | 21266 | 200 | MG | FILM-COATED TABLET | |||||||
| 125302011 | 12530201 | 2 | SS | VFEND | VORICONAZOLE | 1 | 21266 | FILM-COATED TABLET | |||||||||||
| 125302011 | 12530201 | 3 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, 2X/DAY | 19839 | 100 | MG | FILM-COATED TABLET | BID | ||||||
| 125302011 | 12530201 | 4 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 18 ?G, 1X/DAY | 0 | 18 | UG | CAPSULE | QD | |||||||
| 125302011 | 12530201 | 5 | C | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Nasal | 500-50MCG, 2X/DAY (FLUTICASONE PROPIONATE- 500MCG, SALMETEROL XINAFOATE- 50 MCG) | 0 | BID | |||||||||
| 125302011 | 12530201 | 6 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 0.5 MG, 2X/DAY | 0 | .5 | MG | TABLET | BID | ||||||
| 125302011 | 12530201 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, AS NEEDED (ONCE A DAY AT BEDTIME ) | 0 | 10 | MG | TABLET | |||||||
| 125302011 | 12530201 | 8 | C | KEPPRA | LEVETIRACETAM | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID | ||||||
| 125302011 | 12530201 | 9 | C | KEPPRA | LEVETIRACETAM | 1 | Oral | 2500 MG, DAILY (500 MG 2 TABLETS IN AM, 1 TABLET AT NOON AND 2 TABLETS AT BEDTIME) | 0 | 2500 | MG | TABLET | |||||||
| 125302011 | 12530201 | 10 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 25 ?G, 1X/DAY | 0 | 25 | UG | TABLET | QD | ||||||
| 125302011 | 12530201 | 11 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 75 UG, 1X/DAY | 0 | 75 | UG | TABLET | QD | ||||||
| 125302011 | 12530201 | 12 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 200 MG, AS NEEDED (100MG TWICE A DAY) | 0 | 200 | MG | CAPSULE | |||||||
| 125302011 | 12530201 | 13 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 1200 MG, AS NEEDED (EVERY 12 HRS) | 0 | 1200 | MG | TABLET | |||||||
| 125302011 | 12530201 | 14 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY (IN THE EVENING) | 0 | 40 | MG | TABLET | QD | ||||||
| 125302011 | 12530201 | 15 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Nasal | UNK, AS NEEDED (108 MCG/ACT 2 PUFFS INHALATION EVERY 4 HRS) | 0 | ||||||||||
| 125302011 | 12530201 | 16 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 500 MG, DAILY | 0 | 500 | MG | TABLET | |||||||
| 125302011 | 12530201 | 17 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 250 MG, 1 TABLET DAILY FOR 4 DAYS | 0 | 250 | MG | TABLET | QD | ||||||
| 125302011 | 12530201 | 18 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | ||||||
| 125302011 | 12530201 | 19 | C | ECHINACEA | ECHINACEA, UNSPECIFIED | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | ||||||||
| 125302011 | 12530201 | 20 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125302011 | 12530201 | 1 | Aspergillus infection |
| 125302011 | 12530201 | 2 | Bronchopulmonary aspergillosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125302011 | 12530201 | Dyspnoea | |
| 125302011 | 12530201 | Product use issue | |
| 125302011 | 12530201 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |